RohanGanguliMD

PubMed

• 1 citations
  Over 30 years of STEP: The Pittsburgh experience with first-episode psychosis.
  Helen J Wood, Nev Jones, Shaun M Eack, K N Roy Chengappa, Konasale M Prasad
  Early Intervention in Psychiatry. 2024-10-01
• 11 citations
  Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia.
  Martin Strassnig, Jennifer Clarke, Steve Mann, Gary Remington, Rohan Ganguli
  Early Intervention in Psychiatry. 2017-06-01
• 11 citations
  Adherence to Diabetes Medication in Individuals with Schizophrenia: A Systematic Review of Rates and Determinants of Adherence.
  Paul Gorczynski, Hiren Patel, Rohan Ganguli
  Clinical Schizophrenia & Related Psychoses. 2017-01-11

Journal Articles

• Family planning and parenthood needs of women with severe mental illness: Clinicians’ perspective.  
  McLennan, J., & Ganguli, R*, Community Mental Health Journal
• Clozapine: Acute and maintenance treatment in late-life psychoses.  
  Richards, S.S., Sweet, R.A., & Ganguli, R, The American Journal of Geriatric Psychiatry
• Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: Probable effects of family history of schizophrenia?  
  Nimgaonkar, V.L., Zhang, X.R., Caldwell, J.G., Ganguli, R., & Chakravarti, A, American Journal of Medical Genetics
• Weight reduction in schizophrenia by lifestyle change: a randomized controlled clinical trial.  
  Ganguli, R., Brar J.S, Canadian Journal of Diabetes
• Importance of metabolic syndrome for South Asians.  
  Ganguli, R, Asian Journal of. Psychiatry
• Improving the health of mental health consumers: Effective policies and practices.  
  Everett, A., Mahler, J., Biblin, J., Ganguli, R., & Mauer, B, International Journal of Mental Health
• Predictors of aripiprazole treatment continuation in hospitalized patients.  
  Coley, K.C., Fabian, T.J., Kim, E., Ammerman, D.K., Scipio, T.M., Saul, M.I. Ganguli, R, Journal of Clinical Psychiatry
• Monitoring and managing weight gain in the mentally ill.  
  Ganguli, R., Vreeland, B., & Newcomer, J.W, Journal of Clinical Psychiatry
• Behavioral therapy for weight loss in patients with schizophrenia.  
  Ganguli, R, Journal of Clinical Psychiatry
• Are older antipsychotic drugs obsolete?  
  Ganguli, R,. & Strassnig, M, British Medical Journal
• Increasing energy expenditure is important to enhance management of antipsychotic-associated weight gain.  
  Ganguli, R., & Brar, J.S, Journal of Clinical Psychiatry
• Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.  
  Brar, J.S., Ganguli, R*, Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R, Journal of Clinical Psychiatry
• Rationale and strategies for switching antipsychotics.  
  Ganguli, R, American Journal of Health System Pharmacies
• Obesity and medical illnesses in psychiatric patients admitted to a long-term psychiatric facility.  
  Levine, J., Chengappa, K.N.R., Pate,l A., Vagnucci, A., John, V., Brar, J.S., Chalasani, .L, Parepally, H., & Ganguli, R*, Journal of Psychiatric Practice
• Review of Experimental Design in Psychiatry: Research Methods for Clinical Practice.  
  Ganguli, R, Canadian Journal of Psychiatry
• Weight Gain Associated with Antipsychotic Drugs.  
  Ganguli, R, Journal of Clinical Psychiatry
• Functional Hypofrontality and Working Memory Dysfunction in Schizophrenia.  
  Carter, C.S., Perlstei,n W.M., Ganguli, R., Brar, J.S., Mintun, M., & Cohen, J.D, American Journal of Psychiatry
• Risperidone for treatment- refractory schizophrenia.  
  Tanner, T.B., Ganguli, R., Reddy, R., Allen, M., & Field, K, American Journal of Psychiatry
• Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples.  
  Nimgaonkar, V.L., Sanders, A.R., Ganguli, R., Zhang, X.R., Brar, J.S., Hogge, W., Fann, W.E., Patel, P.I., & Chakravarti, A, American Journal of Medical Genetics
• Slow- wave sleep and symptomatology in schizophreni.a and related psychotic disorders.  
  Keshavan, M.S., Miewald, J., Haas, G, Sweeney, J., Ganguli, R., & Reynolds, C.F, Journal of. Psychiatric.Research
• Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: probable effects of family history of schizophrenia.  
  Nimgaonkar, V.L., Zhang, X.R., Caldwell, J.G., Ganguli, R., & Chakravart,i A, American Journal of Medical Genetics
• Cooccurrence of schizophrenia and Treacher Collins Syndrome.  
  Nimgaonkar, V.L., Scott, J.A., Brar, J.S., Ganguli, R., & Chakravarti, A, American Journal of Medical Genetics
• Should chronic treatment refractory akathisia be an indication for the use of Clozapine in schizophrenic patients?  
  Levin, H., Chengappa, K.N.R., Kambhampati, R.K., Madhavi, N., & Ganguli, R, Journal of Clinical Psychiatry
• Clozapine for the treatment of adolescents with schizophrenia.  
  Birmaher, B., Baker, R., Kapur, S., Quintana, H., & Ganguli, R, Journal of the American Academy of Child and Adolescent Psychiatry
• Differences in interleukin-2 production in blacks and whites.  
  Ganguli, R., & Rabin, B.S, New England Journal of Medicine
• Join now to see all

Books/Book Chapters

• The biology of schizophrenia. 
  Chapter: The biological basis of psychiatric treatment 
  Keshavan, M.S., & Ganguli, REditors: R. Pohl & S. Gershon.S. Karger and Co
• Behavioral treatments for weight management in schizophrenia. 
  Chapter: Medical Illness and Schizophrenia, 2nd 
  Ganguli, R., Cohn, T.,& Faulkner, GEditors: J.M. Meyer & H.A. Nasrallah.Ed. Washington DC: American Psychiatric Press, Inc, Washington, DC
• HLA and Psychiatric Disease in HLA & Human Disease . 
  Wright, P., Nimgaonkar, V., Ganguli, R., & Murray, R.MEditors: P. Wright & R. Murray.Academic Press
• Clinical and immunological characteristics of a subgroup of patients suffering from schizophrenia. 
  Chapter: Advances in Biological Psychiatry: Vol. 18. Immunological Alterations in Psychiatric Diseases 
  Ganguli, R., & Gubbi. AEditors: A.E. Henneberg & W.P. Kaschka.Basel, Switzerland: Karger
• Cytokine abnormalities in schizophrenia: A review of their pathogenic significance, with particular reference to the autoimmune hypothesis. 
  Chapter: Current Update in Psychoimmunology - Key Topics in Brain Research 
  Ganguli, REditors: G. Wieselmann.New York: SpringerWienNewYork, New York
• Developing a Medication Information Workstation for Patients. 
  Chapter: Interactive Technology and the New Paradigm for Healthcare 
  Tanner, T.B., Gitlow, S., Ganguli, R., Kubacka, R., Bulsant, B.H., & Epstein, B.AEditors: K. Morgan, R.M. Satava, H.B. Sieburg, R. Mattheus, & J.P. Christensen.Amsterdam: IOS Press & Ohmsha, Amsterdam
• Clinical correlates of immune dysfunction in a subgroup of schizophrenic patients. 
  Chapter: Past, Present and Future of Psychiatry 
  Ganguli, R., Brar, J.S., Damaraju, C.V., Gubbi, A.V., Yang, Z.W., Chengappa, K.N.R., & Rabin, B.SEditors: A. Beigel, J.J. LopezIbor, J.A. Costa & E. Silva E.River Edge, NJ: World Scientific, New Jersey
• Reduced REM latency in schizophrenia:Pathophysiological mechanisms. 
  Chapter: Biological Psychiatry 
  Keshavan, M.S., Reynolds, C.F., Houck, P., & Ganguli, REditors: G. Racagni, N. Brunello & T. Fukuda.Amsterdam: Excerpta Medica, Amsterdam
• Immunological alterations. 
  Chapter: Drug Induced Dysfunction in Psychiatry 
  Chengappa, K.N.R., Nimgaonkar, V.L., & Ganguli, REditors: Keshavan & G. Kennedy.New York: Hemisphere Publications, New York
• Interaction between the central nervous system and the immune system. 
  Chapter: .), Progress in Autoimmunity 
  Rabin, B.S., Ganguli, R., Lysle, D., & Cunnick, TEditors: P.E. Bigazzi, G. Wick & K. Wicher.New York: Marcel Dekker, Inc, New York
• Semiography of tremor in alcohol withdrawal. 
  Mellor, C.S., & Ganguli, REditors: Currents in Alcoholism (Vol. 5, 207-212).New York: Grune & Stratton. PMID, New York
• Multiple autoantibodies and autoimmune disease in schizophrenic patients: Evidence for an autoimmune pathogenesis. 
  Chapter: Interactions among CNS, neuroendocrine and immune systems 
  Ganguli, R., Rabin, B.S., & Kelly, R.HEditors: J. Hadden, K. Masek & G. Nistico.Rome: Pythagora Press
• Lymphocyte subpopulations in schizophrenics and normals and the effects of varying antipsychotic dosage. 
  Ganguli, R., Rabin, B.S., Raghu, U., & Ulrich, REditors: E. Kurstak, J.Z. Lipowski & P.V. Morolov.Plenum, New York
• Computerized initial and discharge evaluations. 
  Chapter: Clinical Care and Information Systems in Psychiatry 
  Mezzich, J.E., Dow, J.T., Ganguli, R., Munetz, M., & Segal, MEditors: J.E. Mezzich.American Psychiatric, Washington, DC
• Medical aspects. 
  Chapter: Practice of inpatient behavior therapy: Clinical guide 
  Ganguli, REditors: M. Hersen.Grune & Stratton Inc, New York
• The rational use of psychotropic drugs. 
  Ganguli, RUrban Health
• Medical assessment. 
  Ganguli, REditors: M. Hersen, A.E. Kazdin & A.S. Bellack.Pergamon, New York
• Future perspectives in behavior therapy 
  Ganguli, R. & Detre, T.PNew York
• Psychopharmacology and behavior therapy. 
  Ganguli, R. & Detre, T.PNew York
• Join now to see all

Abstracts/Posters

• The stability and interrelationships of CPT-AX and stroop performance in schizophrenia.
  Barch, D., Cohen, J.D., Servan-Schreiber, D., Ganguli, R, Schizophrenia Research
• Towards a phenomenological understanding of psychosis: Trait perfectionism in persons with psychotic illnesses.
  Hassan, S., Ganguli, R., Flett, G.L., Hewitt, P.L, Schizophrenia Research
• Effect of atomoxetine on negative symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial.
  Ganguli, R., Brar, J.S., & Chang, J, Schizophrenia Research
• Weight gain in patients treated with risperidone and olanzapine.
  Ganguli, R,, Brar, J.S., & Ayrton, Z, Biological Psychiatry
• Obsessive compulsive symptoms in clozapine treated patients.
  Levin, H., Ganguli, R., Brar, J.S., Mehta, N., & Habibi, S, Biological Psychiatry
• The effects of risperidone and olanzapine on the indications for clozapine.
  Ganguli, R. & Brar, J.S, Psychopharmacology Bulletin
• Indications for clozapine before and after the introduction of risperidone.
  Ganguli, R,, & Brar, J,S, Psychopharmacology Bulletin
• Autoimmune diseases in first degree relatives of schizophrenic and control subjects.
  Ganguli, R., Brar, J.S., Vemulapalli, H.K., & Nimgaonkar, V.L, Biological Psychiatry
• rCBF (015 PET) during cognitive and physiological stimulation in schizophrenics.
  Ganguli, R., Mintun, M.A., Becker, J.T., Brar, J.S., Diehl, D., DeLeo, M. (...) Martidis, A, Biological Psychiatry
• Decreased mitogen-stimulated IL-2 production in first episode drug-naive schizophrenic patients.
  Ganguli, R., Yang, Z.W., Chengappa, K.N.R, Brar, J.S., Shurin, G., & Rabin, B.S, Schizophrenia Research
• Decreased PHA stimulated IL-2 production in drug-naive schizophrenics.
  Ganguli, R., Yang, Z.W., Chengappa, K.N.R., Brar, J.S., Shurin, G., & Rabin, B.S, Biological Psychiatry
• Association studies in schizophrenia using dopamine D3 receptor gene polymorphism.
  Nimgaonkar, V.L., Zhang, X.R., Caldwell, J.G., Ganguli, R., & Chakravarti, A, Schizophrenia Research
• The functional neuroanatomy of memory in schizophrenia: An O15H2O PET study during supraspan memory performance.
  Ganguli, R., Mintun, M., Carter, C., Sarma, R., Brar, J.S., Nichols, T., Benington, E, Schizophrenia Research
• Association between the dopamine D3 receptor gene locus and liability to schizophrenia, as well as its age of onset.
  Nimgaonkar, V.L., Zhang, X.R., Brar, J., DeLeo, M., Hogge, W., Ganguli, R., & Chakravarti, A, Schizohrenia Research
• Trait perfectionism and perfectionistic self-presentation in early psychosis.
  Hassan, S., Ganguli, R., Flett, G.L., & Hewitt, P.L, Early Intervention in Psychiatry
• Efficacy of clozapine vs haloperidol in a long term clinical trial: Preliminary findings.
  Schooler, N., Kane, J., Marder, S., Baker, R., Safferman, A., Wirshing, W., Ames, D., Ganguli, R., Borenstein, M, Schizophrenia Research
• Hypofrontality and working memory dysfunction in schizoprenia.
  Cohen, J.D., Ganguli, R., Carter, C., Brar, J., Nichols, T., DeLeo, M., & Mintun, M, Biological Psychiatry
• The stability and interrelationships of CPT-AX and Stroop performance in schizophrenia.
  Barch, D.M., Cohen, J.D., Servan-Schreiber, D., & Ganguli, R, Biological Psychiatry
• Reduced fertility in schizophrenia: Here to stay?
  Ward, S., Weston, N., Brar, J.S., DeLeo, M., Ganguli, R., & Nimgaonkar, V.L, Biological Psychiatry
• Efficacy of Clozapine vs. Haloperidol in a long-term clinical trial: Preliminary results.
  Ames, D., Wirshing, W.C., Kane, J., Schooler, N., Marder, S.R., Baker, R., Safferman, A., Ganguli, R. (…) Borenstein, M, Biological Psychiatry
• Efficacy of clozapine versus haloperidol in a long-term clinical trial.
  Kane, J.M., Schooler, N.R., Marder, S., Wirshing, W., Ames, D., Umbricht, D (…) Ganguli, R, Schizophrenia Research
• Weight gain and antipsychotics in schizophrenia.
  Lake, M.B., Ganguli, R., Kuhn, B., & Gubbi, A, Schizophrenia Research
• Relapse and changes in cytokine and antibody production in schizophrenia.
  Ganguli, R,, Rabin, B.S., Brar, J.S., & Gubbi, A.V, Schizophrenia Research
• The effect of risperidone on the indications for clozapine.
  Brar, J.S.,& Ganguli, R, Biological Psychiatry
• Effect of clozapine on negative symptoms in schizophrenic patients with minimal positive symptoms.
  Brar JS, Chengappa KNR, Sandman AR, Kreinbrook SB, Sheth SA, & Ganguli R, Biological Psychiatry
• Join now to see all

Lectures

• Efficacy of behavioral treatment for weight loss in schizophrenia as compared to active controls and usual care. 
  World Psychiatric Association International Congress; Beijing, China
• Co-morbid cardiovascual. 
  Panel Discussant on Addictions and Mental Health; Toronto, Ontario
• Lifestyle treatments to reduce adverse weight and metabolic effects. 
  Adipogenic and Metabolic Effects of Antipsychotic Drugs Conference; Newark, New Jersey
• Reducing the risk of cardiovascular disease and diabetes in serious mental illness. 
  Grand Rounds, Douglas and McGill University; Montreal, Quebec
• Weight reduction in schizophrenia, by lifestyle change: a randomized clinical trial. 
  2nd National Obesity Summit; Montreal, Quebec
• Internal and external barriers to accessing treatment for mental health issues in the South Asian community. 
  The Ripple Effect Wellness Organization; Brampton, Ontario
• Managing co-morbidity south asian perspective. 
  The Indian Global Psychiatric Initiative 2011; New Delhi, India
• Lifestyle interventions to reduce the risk of cardiovascular disease in serious mental illness 
  Annual National Conference of Indian Psychiatric Society; New Delhi, India
• Treatment of obesity and other metabolic abnormalities in persons with serious mental illnesses 
  International Conference on Schizophrenia (IConS) IV of SCARF 2010; Chennai, India
• Treating and preventing metabolic problems in persons with schizophrenia 
  University of Texas Medical Branch; Houston, Texas
• Schizophrenia: special reference to persons of South Asian descent 
  ”. Canadian Psychiatric Association 61st Annual Conference; Toronto, Ontario
• Behavioral Strategies for weight management in people with severe and persistent mental disorders. 
  McMaster University, Hamilton, Ontario
• A clinical trial for weight reduction: lifestyle interventions in routine clinical care. 
  American Psychiatric Association Annual Meeting; New Orleans, Louisiana
• Co-morbid medical disorders in psychoses. 
  The Inaugural Indian Global Psychiatric Initiative 2010; Jaipur, India
• Co-morbid cardiovascular. 
  Health Achieve Conference; Toronto, Ontario
• Reducing the risk of heart disease and diabetes in serious mental illness. 
  New York State Office of Minority Health Annual Nursing Conference; Ellenville, New York
• Using evidence to provide safer care in mental health. 
  Canadian Patient Safety Institute; Toronto, Ontario
• Obesity and the metabolic syndrome with special reference to South Asians. 
  Texas Medical Association Conference; Houston, Texas
• Efficacy of maintenance treatment in sustaining weight loss: a randomized controlled clinical trial. 
  American Psychiatric Association Annual Meeting; San Francisco, California
• Atmoxetine effects on negative symptoms in schizophrenia: a randomized clinical trial. 
  International Congress on Schizophrenia Research; San Diego, California
• Educational and behavioral interventions for weight loss. 
  National Association of State Mental Health Program Directors, New York
• Electronic documentation for psychiatrists. 
  Centre for Addiction and Mental Health; Toronto, Ontario
• Join now to see all

Other

• Lack of association between schizophrenia and a pancreatic phospholipase A-2 gene (PLA2G1B) polymorphism. 
  Strauss, J., Xhang, X.R., Barron, Y., Ganguli, R., & Nimgaonkar, V.L, Molecular Psychiatry
• A clinical trial to test the feasibility of a telehealth psychoeducational intervention for persons with schizophrenia and their families: Intervention and 3-month f... 
  Rotondi, A..J., Haas, G.L., Anderson, C.M., Newhill, C.E., Spring, M.B., Ganguli, R., Gardner, W.B., Rosenstock, J.B., Rosenstock, J.B, Rehabilitation Psychology
• Nimgaonkar, V.L. (2004). Evaluation of familial influences on the course and severity of schizophrenia among US and Indian cases. 
  Deshpande, S.N., Bhatia, T., Wood, J., Brar, J.S., Thelma, B.K., Ganguli, R, Social Psychiatry & Psychiatric Epidemiology
• Nutritional assessment of patients with schizophrenia: A preliminary study. 
  Strassnig, M., Brar, J.S., & Ganguli, R*, Schizophrenia Bulletin
• Body mass index and quality of life in community- dwelling patients with schizophrenia. 
  Strassnig, M., Brar. J.S., & Ganguli. R*, Schizophrenia Research
• Cytokine alterations in schizophrenia: treatment implications. 
  Levine, J., Chengappa, K.N.R., & Ganguli, R*, Essential Psychopharmacology
• Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET study. 
  Ganguli, R., Singh, A., Bras, J.S., Carter, C., & Mintun, M, Schizophrenia Research
• Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone. 
  Mullen, B., Brar, J.S., Vagnucci, A.H., & Ganguli, R*, Schizophrenia Research
• Clozapine and haloperidol in moderately refractory schizophrenia: A 6-month randomized and double-blind comparison. 
  Kane, J.M., Marder, S.R,. Schooler, N.R., Wirshing, W.C., Umbricht, D,. Baker, R.W., Wirshing, D.A., Safferman, A., Ganguli, R. (…) Borenstein, M, Archives of General Psychiatry
• Weight gain over four months in schizophrenia patients: A comparison of olanzapine and risperidone. 
  Ganguli, R., Brar, J.S., Ayrton, Z, Schizophrenia Research
• Lack of association between schizophrenia and a CAG repeat polymorphism of the hSKCa3 gene in a North Eastern US sample. 
  Chowdari, K.V., Wood, ., Ganguli, R., Gottesman, I., & Nimgaonkar, V.L, Molecular Psychiatry
• Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. 
  Strassnig, M., Brar, J.S.,& Ganguli, R*, Schizophrenia Research
• Schizophrenia and the serotonin transporter gene. 
  Rao, D., Jonsson, E.G., Paus, S., Ganguli, R., Nothen, M., & Nimgaonkar, V.L, Psychiatric Genetics
• Mini- Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophrenia. 
  Ganguli, R, Brar, J.S., Vemulapalli, H., Jafar, H., Ahuja, R., Sharma, .S, & Wirth, R.J, Schizophrenia Research
• The effects of risperidone and olanzapine on the indications for clozapine. 
  Ganguli, R., & Brar, J.S, Psychopharmacology Bulletin
• Isolation of a novel potassium channel gene hSDCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? 
  Chandy, K.G., Fantino, E., Wittekindt, O., Kalman, K., Tong, L.L., Ho, T.H., Gutman G.A., Crocq, M.A., Ganguli, R. (…) D.J., Gargus, J.J, Molecular Psychiatry
• 5-HT2 receptor gene locus: Association with schizophrenia or treatment response not detected. 
  Nimgaonkar, V.L., Zhang, X.R., Brar, J.S., DeLeo, M., & Ganguli, R, Psychiatric Genetics
• Fertility in schizophrenia: results from a contemporary US cohort. 
  Nimgaonkar, V.L., Ward, S.E., Agarde, H., Weston, N., & Ganguli, R, Acta Psychiatrica Scandinavica
• Negative association of schizophrenia with HLA DQB1*0602: Evidence from a second African- American cohort. 
  Nimgaonkar, V.L., Rudert, W.A., Zhang, X., Trucco, M., & Ganguli, R, Schizophrenia Research
• A PET brain mapping study of auditory verbal supraspan memory vers.us visual fixation in schizophrenia. 
  Ganguli, R., Carter, C.S., Mintun, M., Brar, J.S., Becker, J.T., Sarma, R, Nichels, T., & Bennington, E, Biological Psychiatry
• Smoking affects plasma soluble IL-2 receptors in schizophrenic patients (in reply). 
  Ganguli, R., & Brar, J.S, Archives of General Psychiatry
• Web-based psychoeducational intervention for persons with schizophrenia and their supporters: One-year outcomes. 
  Rotondi, A.J., Anderson, C.M., Haas, G.L., Back, S.M., Spring, M.B., Ganguli, R., Newhill, C., Rosenstock, J, Psychiatric Services
• Eating behaviour in individuals with psychotic illnesses. 
  Park, N., Hassan, S., & Ganguli, R, Obesity
• Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: Preliminary study. 
  Strassing, M., Brar, J.S., & Ganguli, R*, Diabetes, Metabolic Syndrome, and Obesity: Targets and Therapy
• Diabetes resolution following a discontinuation of a second-generation antipsychotic: Three cases. 
  Strassing, M., Awerbuck, J., & Ganguli, R, Clinical Schizophrenia & Related Psychoses
• Join now to see all